Cervical priming before first trimester aspiration abortion: a single blind study comparing gemeprost 1 mg and prostaglandin E2 10 mg pessaries.
Mackenzie
I Z
IZ
Jackson
C
C
Mckinlay
E
E
Millar
J
J
D000019:Abortifacient Agents; D000028:Abortion, Induced; D001695:Biology; D001723:Birth Rate; D002584:Cervix Uteri; D003710:Demography; D019049:Developed Countries; D004194:Disease; D004703:Endocrine System; D005060:Europe; D005193:Family Planning Services; D005298:Fertility; D005835:Genitalia; D005836:Genitalia, Female; D006470:Hemorrhage; D015994:Incidence; D010298:Parity; D010827:Physiology; D011153:Population; D011157:Population Dynamics; D011247:Pregnancy; D011261:Pregnancy Trimester, First; D011446:Prospective Studies; D011453:Prostaglandins; D012098:Reproduction; D012106:Research; D012107:Research Design; D012816:Signs and Symptoms; D006113:United Kingdom; D014566:Urogenital System; D014595:Uterine Perforation; D014599:Uterus
D000019:Abortifacient Agents; D011453:Prostaglandins
Abortifacient Agents--administraction and dosage; Abortifacient Agents--side effects; Abortion, Drug Induced; Abortion, Induced; Biology; Bleeding--analysis; Cervical Effects; Cervix; Demographic Factors; Developed Countries; Diseases; Endocrine System; Europe; Family Planning; Fertility; Fertility Control, Postconception; Fertility Measurements; Genitalia; Genitalia, Female; Incidence; Measurement; Northern Europe; Parity; Perforations; Physiology; Population; Population Dynamics; Pregnancy; Pregnancy, First Trimester; Prospective Studies; Prostaglandins--administraction and dosage; Prostaglandins--side effects; Reproduction; Research Methodology; Signs And Symptoms; Studies; United Kingdom; Urogenital System; Uterine Perforation; Uterus